DSpace

DSpace at RU >

Search Results

 
for  

Results 1-50 of 129.

Sort items by In order  |  Results/Page Authors/record

Item hits:

Full TextIssue DateTitleAuthor(s)
2011Re: Axel Heidenreich. Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol 2011;59:495-7.Barentsz, J.O.; Dickinson, L.; Sciarra, A.
2011Evaluation of axillary lymph nodes by diffusion-weighted MRI using ultrasmall superparamagnetic iron oxide in patients with breast cancer: Initial clinical experience.Nakai, G.; Matsuki, M.; Harada, T.; Tanigawa, N.; Yamada, T.; Barentsz, J.O.; Narumi, Y.
2011Comparison of nodal risk formula and MR lymphography for predicting lymph node involvement in prostate cancerDeserno, W.M.L.L.G.; Debats, O.A.; Rozema, T.; Fortuin, A.S.; Heesakkers, R.A.M.; Hoogeveen, Y.L.; Peer, P.G.M.; Barentsz, J.O.; Lin, E.N. van
2011Quantitative analysis of lymph vessel characteristics in organ confined prostate cancerNiekerk, G.C. van; Hulsbergen- van de Kaa, C.A.; Barentsz, J.O.; Witjes, J.A.; Laak, J.A.W.M. van der
2011State-of-the-art uroradiologic imaging in the diagnosis of prostate cancerHeijmink, S.W.T.P.J.; Futterer, J.J.; Strum, S.S.; Oyen, W.J.G.; Frauscher, F.; Witjes, J.A.; Barentsz, J.O.
2011Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meetingDickinson, L.; Ahmed, H.U.; Allen, C.; Barentsz, J.O.; Carey, B.; Futterer, J.J.; Heijmink, S.W.T.P.J.; Hoskin, P.J.; Kirkham, A.; Padhani, A.R.; Persad, R.; Puech, P.; Punwani, S.; Sohaib, A.S.; Tombal, B.; Villers, A.; Meulen, J. van der; Emberton, M.
2011Feasibility of a pneumatically actuated MR-compatible robot for transrectal prostate biopsy guidanceYakar, D.; Schouten, M.G.; Bosboom, D.G.H.; Barentsz, J.O.; Scheenen, T.W.J.; Futterer, J.J.
2011Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapseWeidner, A.M.; Lin, E.N. van; Dinter, D.J.; Rozema, T.; Schoenberg, S.O.; Wenz, F.; Barentsz, J.O.; Lohr, F.
2011Automated 3-dimensional segmentation of pelvic lymph nodes in magnetic resonance imagesDebats, O.A.; Litjens, G.J.S.; Barentsz, J.O.; Karssemeijer, N.; Huisman, H.J.
2011MRI-guided breast biopsy at 3T using a dedicated large core biopsy set: feasibility and initial resultsMeeuwis, C.; Mann, R.M.; Mus, R.D.M.; Winkel, A.; Hitge-Boetes, C.; Barentsz, J.O.; Veltman, J.
2011Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies.Leeuwen, P.J. van; Kolble, K.; Huland, H.; Hambrock, T.; Barentsz, J.O.; Schroder, F.H.
2011Discriminating cancer from noncancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation studyScheenen, T.W.J.; Futterer, J.J.; Weiland, E.; Hecke, P. van; Lemort, M.; Zechmann, C.; Schlemmer, H.P.; Broome, D.; Villeirs, G.; Lu, J.; Barentsz, J.O.; Roell, S.; Heerschap, A.
2011Advances in magnetic resonance imaging: how they are changing the management of prostate cancerSciarra, A.; Barentsz, J.O.; Bjartell, A.; Eastham, J.; Hricak, H.; Panebianco, V.; Witjes, J.A.
2011Diagnostic value of magnetic resonance lymphography in preoperative staging of clinically negative necks in squamous cell carcinoma of the oral cavity: A pilot studyWensing, B.M.; Deserno, W.M.L.L.G.; Bondt, R.B. de; Marres, H.A.M.; Merkx, M.A.W.; Barentsz, J.O.; Hoogen, F.J. van den
2011Prostate cancer: multiparametric MR imaging for detection, localization, and stagingHoeks, C.M.A.; Barentsz, J.O.; Hambrock, T.; Yakar, D.; Somford, D.M.; Heijmink, S.W.T.P.J.; Scheenen, T.W.J.; Vos, P.C.; Huisman, H.J.; van Oort, I.M.; Witjes, J.A.; Heerschap, A.; Futterer, J.J.
2011Initial results of 3-dimensional 1H-magnetic resonance spectroscopic imaging in the localization of prostate cancer at 3 Tesla: should we use an endorectal coil?Yakar, D.; Heijmink, S.W.T.P.J.; Hulsbergen- van de Kaa, C.A.; Huisman, H.J.; Barentsz, J.O.; Futterer, J.J.; Scheenen, T.W.J.
2011In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coilKobus, T.; Hambrock, T.; Hulsbergen- van de Kaa, C.A.; Wright, A.J.; Barentsz, J.O.; Heerschap, A.; Scheenen, T.W.J.
2011Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancerHambrock, T.; Somford, D.M.; Huisman, H.J.; Oort, I.M. van; Witjes, J.A.; Hulsbergen- van de Kaa, C.A.; Scheenen, T.W.J.; Barentsz, J.O.
2010Structured reporting.Barentsz, J.O.
2010The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast.Mann, R.M.; Loo, C.E.; Wobbes, T.; Bult, P.; Barentsz, J.O.; Gilhuijs, K.G.; Hitge-Boetes, C.
2010Perineal descent and patients' symptoms of anorectal dysfunction, pelvic organ prolapse, and urinary incontinence.Broekhuis-Smallegoor, S.R.; Hendriks, J.C.M.; Futterer, J.J.; Vierhout, M.E.; Barentsz, J.O.; Kluivers, K.B.
2010Focal therapy in prostate cancer-report from a consensus panel.Rosette, J.J.M.H.C. de la; Ahmed, H.; Barentsz, J.O.; Johansen, T.B.; Brausi, M.; Emberton, M.; Frauscher, F.; Greene, D.; Harisinghani, M.; Haustermans, K.; Heidenreich, A.; Kovacs, G.; Mason, M.; Montironi, R.; Mouraviev, V.; Reijke, T. de; Taneja, S.; Thuroff, S.; Tombal, B.; Trachtenberg, J.; Wijkstra, H.; Polascik, T.
2010Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weighted MRI.Vos, P.C.; Hambrock, T.; Barentsz, J.O.; Huisman, H.J.
2010Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.Yakar, D.; Hambrock, T.; Huisman, H.J.; Hulsbergen- van de Kaa, C.A.; Lin, E.N.J.T. van; Vergunst, H.; Hoeks, C.M.A.; Oort, I.M. van; Witjes, J.A.; Barentsz, J.O.; Futterer, J.J.
2010Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.Hambrock, T.; Somford, D.M.; Hoeks, C.M.A.; Bouwense, S.A.W.; Huisman, H.J.; Yakar, D.; Oort, I.M. van; Witjes, J.A.; Futterer, J.J.; Barentsz, J.O.
2009Staging of endometrial cancer with MRI: Guidelines of the European Society of Urogenital ImagingKinkel, K.; Forstner, R.; Danza, F.M.; Olega, L.; Cunha, T.M.; Bergman, A.; Barentsz, J.O.; Balleyguier, C.; Brkljacic, B.; Spencer, J.A.
2009POP-Q, dynamic MR imaging, and perineal ultrasonography: do they agree in the quantification of female pelvic organ prolapse?Broekhuis-Smallegoor, S.R.; Kluivers, K.B.; Hendriks, J.C.M.; Futterer, J.J.; Barentsz, J.O.; Vierhout, M.E.
2009Imaging modalities for prostate cancer.Futterer, J.J.; Barentsz, J.O.; Heijmijnk, S.T.
2009Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.Desar, I.M.E.; Herpen, C.M.L. van; Laarhoven, H.W.M. van; Barentsz, J.O.; Oyen, W.J.G.; Graaf, W.T.A. van der
2009In vivo imaging of the aneurysm wall with MRI and a macrophage-specific contrast agent.Truijers, M.; Futterer, J.J.; Takahashi, S.; Heesakkers, R.A.M.; Blankensteijn, J.D.; Barentsz, J.O.
2009Multiparametrische MRI bij prostaatkankerscreeningHoeks, C.M.A.; Futterer, J.J.; Somford, D.M.; Oort, I.M. van; Huisman, H.J.; Barentsz, J.O.
2009Cost-effectiveness of MR lymphography for the detection of lymph node metastases in patients with prostate cancer.Hovels, A.M.; Heesakkers, R.A.M.; Adang, E.M.M.; Barentsz, J.O.; Jager, G.J.; Severens, J.L.
2009Symptoms of pelvic floor dysfunction are poorly correlated with findings on clinical examination and dynamic MR imaging of the pelvic floor.Broekhuis-Smallegoor, S.R.; Futterer, J.J.; Hendriks, J.C.M.; Barentsz, J.O.; Vierhout, M.E.; Kluivers, K.B.
2009A systematic review of clinical studies on dynamic magnetic resonance imaging of pelvic organ prolapse: the use of reference lines and anatomical landmarks.Broekhuis-Smallegoor, S.R.; Futterer, J.J.; Barentsz, J.O.; Vierhout, M.E.; Kluivers, K.B.
2009Dynamic magnetic resonance imaging: reliability of anatomical landmarks and reference lines used to assess pelvic organ prolapse.Broekhuis-Smallegoor, S.R.; Kluivers, K.B.; Hendriks, J.C.M.; Vierhout, M.E.; Barentsz, J.O.; Futterer, J.J.
2009Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue.Niekerk, G.C. van; Laak, J.A.W.M. van der; Borger, E.; Huisman, H.J.; Witjes, J.A.; Barentsz, J.O.; Hulsbergen- van de Kaa, C.A.
2009Changes in prostate shape and volume and their implications for radiotherapy after introduction of endorectal balloon as determined by MRI at 3T.Heijmink, S.W.T.P.J.; Scheenen, T.W.J.; Lin, E.N.J.T. van; Visser, A.G.; Kiemeney, L.A.L.M.; Witjes, J.A.; Barentsz, J.O.
2009Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.Heesakkers, R.A.M.; Jager, G.J.; Hovels, A.M.; Hoop, B. de; Bosch, H.C. van den; Raat, F.; Witjes, J.A.; Mulders, P.F.A.; Hulsbergen- van de Kaa, C.A.; Barentsz, J.O.
2008Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.Futterer, J.J.; Barentsz, J.O.
2008The importance of the extent of pelvic-lymph-node dissection in the diagnosis of lymph-node metastases in prostate cancer - Authors' reply.Jager, G.J.; Heesakkers, R.A.M.; Witjes, J.A.; Barentsz, J.O.
2008Diffusion and perfusion MR imaging of the prostate.Somford, D.M.; Futterer, J.J.; Hambrock, T.; Barentsz, J.O.
2008Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions.Veltman, J.; Stoutjesdijk, M.; Mann, R.; Huisman, H.J.; Barentsz, J.O.; Blickman, J.G.; Boetes, C.
2008The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis.Hovels, A.M.; Heesakkers, R.A.M.; Adang, E.M.M.; Jager, G.J.; Strum, S.; Hoogeveen, Y.L.; Severens, J.L.; Barentsz, J.O.
2008The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast.Mann, R.M.; Veltman, J.A.; Barentsz, J.O.; Wobbes, T.; Blickman, J.G.; Boetes, C.
2008Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI.Vos, P.C.; Hambrock, T.; Hulsbergen- van de Kaa, C.A.; Futterer, J.J.; Barentsz, J.O.; Huisman, H.J.
2008Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence.Futterer, J.J.; Yakar, D.; Strijk, S.P.; Barentsz, J.O.
2008Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.Hambrock, T.; Futterer, J.J.; Huisman, H.J.; Hulsbergen- van de Kaa, C.A.; Basten, JP van; Oort, I van; Witjes, J.A.; Barentsz, J.O.
2008MR-guided biopsy of the prostate: an overview of techniques and a systematic review.Pondman, K.M.; Futterer, J.J.; Haken, B ten; Kool, LJ Schultze; Witjes, J.A.; Hambrock, T.; Macura, K.J.; Barentsz, J.O.
2008MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.Heesakkers, R.A.M.; Hovels, A.M.; Jager, G.J.; Bosch, H.C. van den; Witjes, J.A.M.; Raat, H.P.; Severens, J.L.; Adang, E.M.M.; Hulsbergen- van de Kaa, C.A.; Futterer, J.J.; Barentsz, J.O.
2007Het volgen van therapeutische cellen met magnetische resonantie.Vries, I.J.M. de; Lesterhuis, W.J.; Barentsz, J.O.; Krieken, J.H.J.M. van; Raymakers, R.A.P.; Oyen, W.J.G.; Adema, G.J.; Heerschap, A.; Hoogerbrugge, P.M.; Punt, C.J.A.; Figdor, C.G.

1 2 3 next

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback